
Overview
Fresenius Kabi Polska specializes in lifesaving medicines and technologies for critically and chronically ill patients across biopharma, medtech, nutrition and pharma. The company also develops blood donation systems with MDR Class III CE certification and supports care for patients throughout the breast cancer journey.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $8,354,596 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 84 days late). All were audited by a statutory auditor.
- 202508/07/2026
- 202408/07/2025
- 202309/07/2024
- 202204/07/2023
- 202107/10/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The sites are available in: English and German.
- fresenius-kabi.comFresenius Kabi Global Website
- zywieniemaznaczenie.plStrona główna | Żywienie ma znaczenieWordPress 6.9ElementorGoogle AnalyticsGoogle Tag ManagerRRank MathLLiteSpeed
- fresenius.comHome | FSEDrupal 11MatomoNginx
Public procurement
1891 tenders recorded as contractor: 499 national ($21,502,549) and 1392 EU ($983,283,659).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 17, 2026 | Dostawa pojemników potrójnych góra-dół do pobierania i preparatyki krwi. | –– | Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Lublinie | |
| Nov 16, 2026 | Supply of medicines, lots 1–41 | –– | Górnośląskie Centrum Medyczne Im. Prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Nov 16, 2026 | Supply of single-use medical equipment | $40,003$40,003 | Szpital Wojewódzki Im. Prymasa Kardynała Stefana Wyszyńskiego w Sieradzu |
The company is the contractor in 903 public sector contracts, worth USD 47.78m in total. They were signed with 151 public buyers. The largest number (2) were signed with Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w Bydgoszczy.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 16, 2026 | Performance of inspections | $1,872 | Samodzielny Publiczny Szpital Kliniczny Im. Prof. Adama Grucy Centrum Medycznego Kształcenia Podyplomowego | |
| Nov 13, 2026 | Inspection: Syringe infusion pump | $159.37 | Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego we Wrocławiu | |
| Nov 13, 2026 | Inspection: Syringe infusion pumps 3 pcs. | $478.12 | Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego we Wrocławiu |
Fresenius Kabi Polska has been a party to 20 cases before the National Appeal Chamber (since 2018). It filed 14 appeals (2 upheld, 2 dismissed, 7 discontinued, 1 rejected). In 6 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Apr 21, 2026 | Contracting authority | Discontinued | Kliniczny Szpital Wojewódzki im. Św. Jadwigi Królowej w Rzeszowie | |
| Apr 12, 2024 | Judgment | Upheld | Szpital Wojewódzki im. Prymasa Kardynała Stefana Wyszyńskiego w Sieradzu | |
| Jan 31, 2024 | Order | – | Samodzielny Publiczny Szpital Kliniczny nr 1 PUM w Szczecinie |
Trademarks
The company holds 8 active trademarks registered with the Polish Patent Office. 10 marks have expired or were not registered. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| żywienie ma znaczenie | Oct 11, 2034 | |
| żywienie ma znaczenie | Sep 24, 2034 | |
| mój Fresubin | Sep 24, 2034 | |
| MOC PŁYNOTERAPII | Nov 13, 2028 | |
| ŻYCIE W PŁYNIE | Dec 14, 2027 |
Job offers
The company has its own careers page: fresenius-kabi.com/work-with-us.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Fresenius Kabi Ag | 54,260 | $7,328,471.10 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Fresenius SE & Co. KGaA (Germany) group, which is its direct owner. The group has 95 companies, 90 of them abroad.
| Name | Country |
|---|---|
| Clinico Medical | |
| Fresenius Digital Technology Polska | |
| Fresenius Kabi Business Services | |
| Audere Medical Services Limited | |
| Avensys UK Group Limited |
Bank accounts
Registered as a VAT taxpayer on 2003-11-30.
19 1880 0009 0000 0011 0102 5041
32 1880 0009 0000 0011 0102 5001
10 1880 0009 0000 0011 0102 5009
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $867.7K$867,654 |
Buildings and premises | $22.3M$22,327,474 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 22, 2026 | Return of additional payments | |
| Feb 28, 2014 | Merger plan | |
| May 6, 2013 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 12, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Zarządca Rozliczeń S.A. | |
| Aug 12, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Zarządca Rozliczeń S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Teva Operations Poland sp. z o.o. | $529,423,373.78 | teva.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A. | $119,621,017.71 | hasco-lek.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne Polfa S.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o. | $102,266,019.67 | lekam.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Sandoz Polska sp. z o.o. | $89,136,265.74 | sandoz.com | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Bioton S.A. | $71,777,247.61 | bioton.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-12-06 | Address change (Al. Aleje Jerozolimskie 134, 02-305, Warszawa → Aleje Jerozolimskie 134, 02-305, Warszawa) | |
| 2015-12-02 | Address change (Hrubieszowska 2, 01-209, Warszawa → Al. Aleje Jerozolimskie 134, 02-305, Warszawa) | |
| 2012-11-27 | Share capital increase (14,130,000.00 PLN → 27,130,000.00 PLN) | |
| 2009-09-07 | Share capital increase (11,304,000.00 PLN → 14,130,000.00 PLN) | |
| 2005-06-07 | Address change (Aleje Jerozolimskie 146d, 02-305, Warszawa → Hrubieszowska 2, 01-209, Warszawa) |
FAQ
Last updated: 2026-10-29